Olivo Martin Sebastian 4
4 · Protara Therapeutics, Inc. · Filed Jun 14, 2021
Insider Transaction Report
Form 4
Olivo Martin Sebastian
Chief Medical Officer
Transactions
- Purchase
Common Stock
2021-06-10$10.08/sh+4,959$49,987→ 9,410 total - Purchase
Common Stock
2021-06-10$10.13/sh+4,934$49,981→ 14,344 total